Kitov Announces Settlement Agreement with Minority Shareholder of Recently Acquired TyrNovo TEL AVIV, Israel, Feb. 10, 2017 (GLOBE NEWSWIRE) -- Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) (TASE:KTOV), an innovative biopharmaceutical company, announced today that, following its...

Kitov Provides Further Update on Formal Investigation by Israeli Securities Authority TEL AVIV, Israel, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) (TASE:KTOV), an innovative biopharmaceutical company, in response to requests made by the NASDAQ...

Kitov Announces Initiation of Formal Investigation by Israeli Securities Authority TEL AVIV, Israel, Feb. 07, 2017 (GLOBE NEWSWIRE) -- Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) (TASE:KTOV), an innovative biopharmaceutical company, announced today that the Israeli...

Kitov Pharmaceuticals to Present at Pioneers 2016, Presented by Joseph Gunnar, in NYC on May 5, 2016 TEL AVIV, Israel, May 04, 2016 (GLOBE NEWSWIRE) -- Kitov Pharmaceuticals (NASDAQ:KTOV) (TASE:KTOV), a  late-stage drug development company, today announced that Dr. J. Paul Waymack,...